{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T17:15:13Z","timestamp":1781198113547,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["MLP0106"],"award-info":[{"award-number":["MLP0106"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.molimm.2021.11.009","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T08:38:04Z","timestamp":1637051884000},"page":"33-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Immunological characterization of rLdTCP1\u03b3 for its prophylactic potential against visceral leishmaniasis in hamster model"],"prefix":"10.1016","volume":"141","author":[{"given":"Apeksha","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deep Chandra","family":"Balodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthik","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailendra","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-3185","authenticated-orcid":false,"given":"Neena","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2021.11.009_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/1687-7942.163407","article-title":"Heat shock proteins and parasitic diseases: part II. Protozoa","volume":"8","author":"Abaza","year":"2015","journal-title":"Parasitol. United J."},{"key":"10.1016\/j.molimm.2021.11.009_bib0010","article-title":"New insights into leishmaniasis in the immunosuppressed","volume":"12","author":"Akuffo","year":"2018","journal-title":"PLoSNegl. Trop. Dis."},{"key":"10.1016\/j.molimm.2021.11.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.molimm.2021.11.009_bib0020","first-page":"2157","article-title":"Pro-and anti-inflammatory cytokines in visceral leishmaniasis","volume":"6","author":"Andargie","year":"2015","journal-title":"J. Cell Sci. Ther."},{"issue":"6","key":"10.1016\/j.molimm.2021.11.009_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0097911","article-title":"Nucleosomal histone proteins of L. donovani: a combination of recombinant H2A, H2B, H3 and H4 proteins were highly immunogenic and offered optimum prophylactic efficacy against Leishmania challenge in hamsters","volume":"9","author":"Baharia","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.molimm.2021.11.009_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003557","article-title":"Recombinant NAD-dependent SIR-2 protein of Leishmania donovani: immunobiochemical characterization as a potential vaccine against visceral leishmaniasis","volume":"9","author":"Baharia","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.molimm.2021.11.009_bib0035","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1573395513666170511115705","article-title":"Leishmania heat shock proteins as effectors of immune evasion and virulence","volume":"13","author":"Bartsch","year":"2017","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.molimm.2021.11.009_bib0040","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2012.10.090","article-title":"Cloning, characterization and sub-cellular localization of gamma subunit of T-complex protein-1 (chaperonin) from Leishmania donovani","volume":"429","author":"Bhaskar","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2021.11.009_bib0045","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1111\/febs.13521","article-title":"The TCP 1\u03b3 subunit of Leishmania donovani forms a biologically active homo\u2010oligomeric complex","volume":"282","author":"Bhaskar","year":"2015","journal-title":"FEBS J."},{"key":"10.1016\/j.molimm.2021.11.009_bib0050","first-page":"439","article-title":"Exploration of antileishmanial activity in heterocycles; results of their in vivo & in vitro bioevaluations","volume":"89","author":"Bhatnagar","year":"1989","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.molimm.2021.11.009_bib0055","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"issue":"7","key":"10.1016\/j.molimm.2021.11.009_bib0060","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2021.11.009_bib0065","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/461230","article-title":"Heat shock proteins: stimulators of innate and acquired immunity","volume":"2013","author":"Colaco","year":"2013","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.molimm.2021.11.009_bib0070","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0035-9203(02)90044-1","article-title":"Mechanisms of pathogenesis: differences amongst Leishmania species","volume":"96","author":"Colmenares","year":"2002","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.molimm.2021.11.009_bib0075","series-title":"Encyclopedic Reference of Immunotoxicology.","article-title":"Lymphocyte proliferation","author":"Crevel","year":"2005"},{"key":"10.1016\/j.molimm.2021.11.009_bib0080","series-title":"Advances in Immunology","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-2776(08)60209-6","article-title":"Delayed hypersensitivity in the mouse","author":"Crowle","year":"1975"},{"key":"10.1016\/j.molimm.2021.11.009_bib0085","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1128\/iai.55.11.2802-2806.1987","article-title":"Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation","volume":"55","author":"Da Silva","year":"1987","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2021.11.009_bib0090","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0166-6851(95)00035-Y","article-title":"Isolation and characterization of the gene encoding the surface membrane 3\u2032-nucleotidase\/nuclease of Leishmania donovani","volume":"71","author":"Debrabant","year":"1995","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0100","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/eji.200425719","article-title":"Decision criteria for resolving isotype switching conflicts by B cells","volume":"35","author":"Deenick","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0105","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"Ding","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0264-410X(00)00207-3","article-title":"Immunization with recombinant LD1 antigens protects against experimental leishmaniasis","volume":"19","author":"Dole","year":"2000","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.molimm.2021.11.009_bib0115","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3390\/microorganisms7120695","article-title":"Protective or detrimental? Understanding the role of host immunity in leishmaniasis","volume":"7","author":"dos Santos Meira","year":"2019","journal-title":"Microorganisms"},{"key":"10.1016\/j.molimm.2021.11.009_bib0120","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1590\/0037-8682-0120-2016","article-title":"Recent updates and perspectives on approaches for the development of vaccines against visceral leishmaniasis","volume":"49","author":"Duarte","year":"2016","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.molimm.2021.11.009_bib0125","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-2478(01)00179-1","article-title":"Analysis of the adjuvant effect of recombinant Leishmania infantum Hsp83 protein as a tool for vaccination","volume":"76","author":"Echeverria","year":"2001","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2021.11.009_bib0130","doi-asserted-by":"crossref","first-page":"e2914","DOI":"10.1371\/journal.pntd.0002914","article-title":"Immune regulation during chronic visceral leishmaniasis","volume":"8","author":"Faleiro","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1597","key":"10.1016\/j.molimm.2021.11.009_bib0135","first-page":"2083","article-title":"Pathogen responses to host immunity: the impact of time delays and memory on the evolution of virulence","volume":"273","author":"Fenton","year":"2006","journal-title":"Proc. Biol. Sci."},{"issue":"3","key":"10.1016\/j.molimm.2021.11.009_bib0140","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.molimm.2021.11.009_bib0145","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/DDDT.S146521","article-title":"Leishmaniasis in humans: drug or vaccine therapy?","volume":"12","author":"Ghorbani","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.molimm.2021.11.009_bib0150","first-page":"318","article-title":"Serological investigations on kala-azar","volume":"40","author":"Ghose","year":"1980","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0155","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jac\/dkr485","article-title":"Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses","volume":"67","author":"Gupta","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"10.1016\/j.molimm.2021.11.009_bib0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108556","article-title":"Th1 stimulatory proteins of Leishmania donovani: comparative cellular and protective responses of rTriose phosphate isomerase, rProtein disulfide isomerase and rElongation factor-2 in combination with rHSP70 against visceral leishmaniasis","volume":"9","author":"Jaiswal","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.molimm.2021.11.009_bib0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1017\/S003118201400184X","article-title":"Immunological consequences of stress-related proteins-cytosolic tryparedoxin peroxidase and chaperonin TCP20-identified in splenic amastigotes of Leishmania donovani as Th1 stimulatory, in experimental visceral leishmaniasis","volume":"142","author":"Jaiswal","year":"2015","journal-title":"Parasitology"},{"issue":"1","key":"10.1016\/j.molimm.2021.11.009_bib0170","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1080\/21505594.2019.1649587","article-title":"Efficient infection of hamster with Leishmania donovani by retro-orbital inoculation","volume":"10","author":"Jim\u00e9nez-Ant\u00f3n","year":"2019","journal-title":"Virulence"},{"key":"10.1016\/j.molimm.2021.11.009_bib0175","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3389\/fmicb.2016.00312","article-title":"Comparative analysis of cellular immune responses in treated Leishmania patients and hamsters against recombinant Th1 stimulatory proteins of Leishmania donovani","volume":"7","author":"Joshi","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0180","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fimmu.2019.00288","article-title":"Immunogenicity and protective efficacy of T-Cell epitopes derived from potential Th1 stimulatory proteins of Leishmania (Leishmania) donovani","volume":"10","author":"Joshi","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2021.11.009_bib0185","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s42003-021-02446-x","article-title":"Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis","volume":"4","author":"Karmakar","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.molimm.2021.11.009_bib0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.actatropica.2011.04.007","article-title":"Studies on the protective efficacy and immunogenicity of Hsp70 and Hsp83 based vaccine formulations in Leishmania donovani infected BALB\/c mice","volume":"119","author":"Kaur","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.molimm.2021.11.009_bib0195","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00436-006-0301-1","article-title":"Leishmania major: common antigen responsible for induction of delayed-type hypersensitivity response in guinea pigs","volume":"100","author":"Khabiri","year":"2007","journal-title":"Parasitol. Res."},{"issue":"3","key":"10.1016\/j.molimm.2021.11.009_bib0200","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00436-013-3716-5","article-title":"Efficacy of Leishmania donovani trypanothione reductase, identified as a potent Th1 stimulatory protein, for its immunogenicity and prophylactic potential against experimental visceral leishmaniasis","volume":"113","author":"Khare","year":"2014","journal-title":"Parsitol. Res."},{"issue":"2","key":"10.1016\/j.molimm.2021.11.009_bib0205","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/cei.12780","article-title":"Immuno protective responses of T helper type1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis","volume":"185","author":"Khare","year":"2016","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0210","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1016\/j.vaccine.2008.08.021","article-title":"Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89\u00b79 to 97\u00b71 kDa offers long-lasting protection against experimental visceral leishmaniasis","volume":"26","author":"Kumari","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.11.009_bib0215","first-page":"373","article-title":"The immune response","author":"Mak","year":"2006","journal-title":"Part I Basic Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2021.11.009_bib0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3347\/kjp.2006.44.1.43","article-title":"Identification of novel Leishmania major antigens that elicit IgG2a response in resistant and susceptible mice","volume":"44","author":"Mohammadi","year":"2006","journal-title":"Korean J. Parasitol."},{"issue":"23","key":"10.1016\/j.molimm.2021.11.009_bib0225","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1016\/j.vaccine.2010.01.015","article-title":"Enhanced efficacy and immunogenicity of 78kDa antigen formulated in various adjuvants against murine visceral leishmaniasis","volume":"28","author":"Nagill","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.11.009_bib0230","series-title":"Pathogenesis of Leishmaniasis","first-page":"1","article-title":"Mechanisms of immunopathology of leishmaniasis","author":"Natarajan","year":"2014"},{"key":"10.1016\/j.molimm.2021.11.009_bib0235","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2012.00144","article-title":"Adjuvants for Leishmania vaccines: from models to clinical application","volume":"3","author":"Raman","year":"2012","journal-title":"Front. Immunol."},{"issue":"27","key":"10.1016\/j.molimm.2021.11.009_bib0240","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2019.04.092","article-title":"Visceral leishmaniasis: an overview of vaccine adjuvants and their applications","volume":"37","author":"Ratnapriya","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2021.11.009_bib0245","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/301326","article-title":"Molecular chaperones of Leishmania: central players in many stress-related and-unrelated physiological processes","volume":"2015","author":"Requena","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.molimm.2021.11.009_bib0250","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.molimm.2016.06.010","article-title":"Comparing Montanide ISA 720 and 50-V2 adjuvants formulated with LmSTI1 protein of Leishmania major indicated the potential cytokine patterns for induction of protective immune responses in BALB\/c mice","volume":"76","author":"Shokri","year":"2016","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/gb-2008-9-2-r35","article-title":"Proteomic analysis of the secretome of Leishmania donovani","volume":"9","author":"Silverman","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0260","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1242\/jcs.056465","article-title":"An exosome-based secretion pathway is responsible for protein export from Leishmania and communication with macrophages","volume":"123","author":"Silverman","year":"2010","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.molimm.2021.11.009_bib0265","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.4049\/jimmunol.1000541","article-title":"Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells","volume":"185","author":"Silverman","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0270","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1128\/CVI.00143-12","article-title":"Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood","volume":"19","author":"Singh","year":"2012","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0275","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1586\/14760584.2014.894467","article-title":"Identifying vaccine targets for anti-leishmanial vaccine development","volume":"13","author":"Sundar","year":"2014","journal-title":"Expert Rev. Vaccines"},{"issue":"2","key":"10.1016\/j.molimm.2021.11.009_bib0280","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.femsim.2004.05.008","article-title":"Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection","volume":"42","author":"Tewary","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.molimm.2021.11.009_bib0285","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.parint.2014.10.003","article-title":"Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis","volume":"64","author":"Thakur","year":"2015","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.molimm.2021.11.009_bib0290","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/5584_2016_135","article-title":"Syrian hamsters as a small animal model for emerging infectious diseases: Advances in immunologic methods","volume":"972","author":"Warner","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molimm.2021.11.009_bib0295","series-title":"Mol. Chaperones Front. Mol. Biol. Oxford Univ","first-page":"90","article-title":"The roles of cytosolic chaperonin, CCT, in normal eukaryotic cell growth","author":"Willison","year":"2001"},{"key":"10.1016\/j.molimm.2021.11.009_bib0300","unstructured":"World Health Organization., 2018. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/leishmaniasis."},{"issue":"8","key":"10.1016\/j.molimm.2021.11.009_bib0305","doi-asserted-by":"crossref","first-page":"e00669","DOI":"10.1128\/AAC.00669-20","article-title":"TCP1\u03b3 subunit is indispensable for growth and infectivity of Leishmania donovani","volume":"64","author":"Yadav","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt B","key":"10.1016\/j.molimm.2021.11.009_bib0310","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.ijbiomac.2020.10.134","article-title":"Leishmania donovani chaperonin TCP1\u03b3 subunit protects miltefosine induced oxidative damage","volume":"165","author":"Yadav","year":"2020","journal-title":"Int. J. Biol. Macromolecules"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589021003199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589021003199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:41:05Z","timestamp":1758980465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589021003199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":62,"alternative-id":["S0161589021003199"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2021.11.009","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological characterization of rLdTCP1\u03b3 for its prophylactic potential against visceral leishmaniasis in hamster model","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2021.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}